RECORD PREVIEW · FIELD RECORD ×2BOUNDED — REAL RELEASED DATA
CLAIM · CLM-b053c93cd3427c5cGRADE VERY_LOW
poria — inflammation
direction BENEFIT · dose UNSPECIFIED · duration UNSPECIFIED
Grade basis — weakest-link ceilings
MODERATEdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
MODERATEconsistency
MODERATEnumeric
3bound studies
Bound studies (3 shown of 3)
STU-7fe689418082ff40ANIMAL · ANIMAL · 2025 · RoB INSUFFICIENT_INFORMATION
3 endpoints
STU-b6030107ace88cdeANIMAL · ANIMAL · 2024 · RoB SOME_CONCERNS
2 endpoints
STU-e3bc6cc3d5c1774fRCT · HUMAN · 2023 · RoB SOME_CONCERNS
2 endpoints
Quantitative observations
observation p < 0.05 · validated
observation p < 0.05 · failed extraction
Opposition screen
SCREEN · 9 candidates considered · 3 bound as opposing
SYNTHESIS SYN-99bc48c3f97237 — outcome QUALITATIVE_ONLY · BENEFIT ×3 · not_assessed_quantitatively · 3 members
PROVENANCE → epmc:40864644, epmc:39106701, epmc:37168053 · PKG e8b64678e52e85fc…
CLAIM · CLM-6b236ebf62808ad3GRADE VERY_LOW
poria constituents — cancer
direction BENEFIT · dose UNSPECIFIED · duration 21 days
Grade basis — weakest-link ceilings
VERY_LOWdesign
LOWdirectness
MODERATEextraction
LOWconfidence
MODERATEmethodology
HIGHconsistency
LOWnumeric
2bound studies
Bound studies (2 shown of 2)
STU-3121d3d7f87c0e95ANIMAL · ANIMAL · 2023 · 21 days · RoB INSUFFICIENT_INFORMATION
4 endpoints
STU-3746f3a60e1feaeaIN_VITRO · IN_VITRO · 2026 · RoB INSUFFICIENT_INFORMATION
1 endpoints
Quantitative observations
observation 21 days · failed extraction
Opposition screen
SCREEN · 3 candidates considered · 1 bound as opposing
SYNTHESIS SYN-9b3c4fd4ba74c0 — outcome QUALITATIVE_ONLY · BENEFIT ×2 · not_assessed_quantitatively · 2 members
PROVENANCE → epmc:37240380, epmc:PPR1158054 · PKG e8b64678e52e85fc…
Bounded preview — representative records only. The full release ships 17 claims and 39 observations.